111 related articles for article (PubMed ID: 6208054)
1. Measurement of endogenous Na+,K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography.
Crabos M; Wainer IW; Cloix JF
FEBS Lett; 1984 Oct; 176(1):223-8. PubMed ID: 6208054
[TBL] [Abstract][Full Text] [Related]
2. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
Henning G; Cloix JF; Wainer IW; Pernollet MG; Devynck MA; Meyer P
Life Sci; 1985 May; 36(18):1787-98. PubMed ID: 2984510
[TBL] [Abstract][Full Text] [Related]
3. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
[TBL] [Abstract][Full Text] [Related]
6. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension.
Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M
Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421
[TBL] [Abstract][Full Text] [Related]
7. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
8. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
Kramer HJ; Baecker A; Weiler E; Liddiard C
Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
[TBL] [Abstract][Full Text] [Related]
9. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
11. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
13. Bile salts as endogenous digitalis like factors.
Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
[TBL] [Abstract][Full Text] [Related]
14. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
15. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
Henning G; Cloix JF
C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931
[TBL] [Abstract][Full Text] [Related]
16. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
17. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension.
Masugi F; Ogihara T; Sakaguchi K; Tomii A; Hasegawa T; Chen Y; Azuma M; Kumahara Y
J Hypertens Suppl; 1988 Dec; 6(4):S351-3. PubMed ID: 2853743
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of cardiodigin, Na+, K+-ATPase inhibitor extracted from mammalian tissues.
Fagoo M; Godfraind T
FEBS Lett; 1985 May; 184(1):150-4. PubMed ID: 2985443
[TBL] [Abstract][Full Text] [Related]
20. Rapid large-scale isolation of biologically active molecules using reversed-phase "flash" chromatography: initial purification of endogenous Na+, K+-ATPase inhibitors from human urine.
Wainer IW; Crabos M; Cloix JF
J Chromatogr; 1985 Mar; 338(2):417-21. PubMed ID: 2987283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
